Clinical Trial Update: Alpha MSH in Ocular Disease [NA]

View source ↗

Summary

A completed clinical trial investigating Alpha MSH for advanced dry macular degeneration; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Dry Macular Degeneration

Drugs mentioned

• Alpha MSH (alpha-melanocyte-stimulating hormone)

Snippet

Sponsor: Duke University | Conditions: Advanced Dry Macular Degeneration | NA | Status: COMPLETED | Results posted: 2022-12-22